register

News & Trends - Pharmaceuticals

Shadow Health Minister challenges government’s Medicare promise: Why are Australians being misled about free GP visits?

Health Industry Hub | February 27, 2025 |

During a heated exchange at Senate Estimates, Shadow Health Minister Senator Anne Ruston questioned the government’s claims that every Australian would be able to see a GP for free under Labor’s $8.5 billion Medicare health policy.

Senator Ruston raised concerns that recent statements by both Federal Health Minister Mark Butler and Prime Minister Anthony Albanese were misleading, setting unrealistic expectations for consumers.

“They’ve stated that Australians will be able to ‘see a GP for free under Labor’ – ‘just bring your Medicare card, not your credit card’,” she stated.

“Are you concerned that Australians are going to have the expectation when they walk into their doctor’s surgery that they won’t have to pay at all?” Senator Ruston pressed.

In response, Senator Malarridirri McCarthy, Minister for Indigenous Australians, defended the government’s position, insisting, “There is certainly no misleading statements by the Health Minister or the Prime Minister.”

While the Coalition, eager to neutralise health as an election battleground, has pledged to match the Medicare funding boost, Senator Ruston clarified that “at no time have I or anybody from the Coalition ever suggested that the only card you needed to take to the doctor going forward was your Medicare card. We have never said that Australians will get access to free GP services without exception.

“I don’t want to lie to Australians and suggest to them that every Australian is going to get at free access to bulk billing services.”

The Australian Medical Association (AMA) President, Dr Danielle McMullen, has also warned that Labor’s Medicare funding boost may not deliver as expected.

“It is quite difficult to see how it will make a huge increase in some of our central, metropolitan areas. We expect there will be higher uptake in rural and regional Australia, but also areas of socio-economic disadvantage,” Dr McMullen stated.

She further added, “It won’t mean that all GPs will be able to bulk bill all patients. In some areas, the cost of providing care will still be too great.”

A recent analysis by the Australian Institute of Health and Welfare (AIHW) revealed a decline in GP bulk-billing rates from a 40-year peak of 89% in 2020 to 78% in 2024, despite recent bulk-billing incentives. Cleanbill’s survey revealed a decline in practices fully bulk-billing patients, dropping to 20.7% at the beginning of this year from 35% two years ago.

Despite the government’s claim that the increased Medicare funding will result in 90% of Australians accessing bulk-billed services from their GP, Senator David Pocock, Independent Senator for the ACT, was sceptical.

“It seems super optimistic given we’ve seen a targeted tripling result basically in no increase in the ACT. Now you’re saying that a more universal tripling will have this extraordinary increase. How is that possible?

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Clinicians shift stance, join calls for PBS subsidy of obesity and weight-loss medicines

Clinicians shift stance, join calls for PBS subsidy of obesity and weight-loss medicines

Health Industry Hub | March 14, 2025 |

Over a third of Australian adults live with obesity, and the National Obesity Strategy estimates the direct and indirect costs […]

More


News & Trends - Pharmaceuticals

Astellas secures new indication for prostate cancer drug

Astellas secures new indication for prostate cancer drug

Health Industry Hub | March 14, 2025 |

Astellas Xtandi (enzalutamide) is now TGA registered for a new indication for patients with non-metastatic hormone-sensitive prostate cancer (nmHSPC) with […]

More


News & Trends - MedTech & Diagnostics

Stakeholder calls intensify as government stalls on genetic discrimination ban

Stakeholder calls intensify as government stalls on genetic discrimination ban

Health Industry Hub | March 14, 2025 |

Calls have intensified for the federal government to honour its commitment to outlaw genetic discrimination in life insurance, as stakeholders […]

More


News & Trends - MedTech & Diagnostics

Pressure mounts to expand home-based therapies in kidney disease: World Kidney Day

Pressure mounts to expand home-based therapies in kidney disease: World Kidney Day

Health Industry Hub | March 13, 2025 |

As Australia marks World Kidney Day, the stark reality is that one in three adults is at risk of chronic […]

More


This content is copyright protected. Please subscribe to gain access.